Brain, Behavior and Evolution
Original Paper
Visual System Alterations in White Zebra FinchesBredenkötter M.a · Engelage J.b · Bischof H.-J.bFederal Institute for Neurobiology, Magdeburg, Department of Biology, University of Bielefeld, Germany
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Published online: January 08, 2008
Issue release date: 1996
Number of Print Pages: 10
Number of Figures: 0
Number of Tables: 0
ISSN: 0006-8977 (Print)
eISSN: 1421-9743 (Online)
For additional information: https://www.karger.com/BBE
Abstract
Visual system anomalies in albino mammals are generally seen to be caused by a lack of retinal pigment and misrouting of retinofugal optic fibers. This study shows that the central visual system of white zebra finches is physiologically different from normally colored (wild type) birds, although the eye pigmentation and the retinofugal projection appear to be normal. Ipsilaterally evoked potentials in our white birds are enhanced in comparison to wild type birds, whereas in albino mammals the ipsilateral component of visually evoked potentials is reduced. Picrotoxin-induced blockade of inhibitory synapses in the ectostriatum reveals remarkable differences between wild type and white zebra finches. In wild type zebra finches, a significant shift of ipsilateral to contralateral stimulus response ratios is observed. However, there is no detectable shift in the white morph. The data suggest that inhibition of ipsilateral stimulus processing, as observed in wild type zebra finches, is significantly reduced in the white morph. Our results indicate that the effects observed in white zebra finches cannot be explained by the theories that have been developed for albinotic animals. We assume that in white zebra finches a genetic defect, which causes the white plumage, is coupled with the demonstrated deviations of inhibitory mechanisms in the central visual system.
© 1996 S. Karger AG, Basel
Related Articles:
Article / Publication Details
Published online: January 08, 2008
Issue release date: 1996
Number of Print Pages: 10
Number of Figures: 0
Number of Tables: 0
ISSN: 0006-8977 (Print)
eISSN: 1421-9743 (Online)
For additional information: https://www.karger.com/BBE
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
